Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

86
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
86
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

385
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
385
Sample Proportion and Population Proportion01:20

Sample Proportion and Population Proportion

5.7K
Collecting samples or responses from an entire population takes significant time and effort, so a researcher collects responses from only a sample of that population. Suppose a study needs to collect information about a specific mobile application. After sample collection, the researcher analyzes the data and discovers that most individuals in the sample use that specific mobile application. The sample proportion measures the number of individuals in a sample who either use or don't use the...
5.7K
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

4.3K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
4.3K
One-Way ANOVA: Equal Sample Sizes01:15

One-Way ANOVA: Equal Sample Sizes

3.5K
One-Way ANOVA can be performed on three or more samples with equal or unequal sample sizes. When one-way ANOVA is performed on two datasets with samples of equal sizes, it can be easily observed that the computed F statistic is highly sensitive to the sample mean.
Different sample means can result in different values for the variance estimate: variance between samples. This is because the variance between samples is calculated as the product of the sample size and the variance between the...
3.5K
Choosing Between z and t Distribution01:25

Choosing Between z and t Distribution

2.9K
The z and the Student t distribution estimate the population mean using the sample mean and standard deviation. However, to decide which distribution to use for a calculation, one needs to determine the sample size, the nature of the distribution, and whether the population standard deviation is known. If the population standard deviation is known and the population is normally distributed, or if the sample size is greater than 30, the z distribution is preferred. The Student t distribution is...
2.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Evaluation of the Clinical Effectiveness and Cost-Effectiveness of Tirzepatide for Type 2 Diabetes in Canada Using Bayesian Transportability Analysis.

Value in health regional issues·2026
Same author

A statistical evaluation of decision-making methods and the efficiency of Bayesian multi-arm multi-stage trials.

Clinical trials (London, England)·2026
Same author

Cross-kingdom microbial associations characterize responsiveness to fecal microbiota transplantation in patients with irritable bowel syndrome.

Journal of translational medicine·2026
Same author

Gut fungal signatures in colorectal cancer and their potential for supporting diagnosis: a multi-cohort metagenomic analysis.

Journal of translational medicine·2026
Same author

Zanubrutinib potentiates polatuzumab vedotin efficacy in DLBCL with concurrent CD79b upregulation.

Annals of hematology·2026
Same author

Elevated FGR protein expression identifies a high-risk subset of diffuse large B-cell lymphoma and a potential therapeutic target.

Frontiers in oncology·2026
Same journal

A Bayesian Optimal Interval Design Considering Efficacy and Toxicity in Early Phase Basket Trials.

Pharmaceutical statistics·2026
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
查看所有相关文章

相关实验视频

Updated: Sep 12, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

目标聚合数据调整方法用于可转移性分析,使用目标人群的汇总级数据.

Yichen Yan1,2, Quang Vuong2, Rebecca K Metcalfe2,3

  • 1Department of Statistical and Actuarial Science, Simon Fraser University, Burnaby, British Columbia, Canada.

Pharmaceutical statistics
|August 6, 2025
PubMed
概括
此摘要是机器生成的。

可转移性分析现在可以使用集成数据 (AgD) 使用一种新的方法,TADA,它调整审查和效果修饰器差异. 这提高了当个人患者数据无法获得时的外部有效性.

关键词:
在聚合级别的数据数据.有关因果推理的推理.审查权重的反向概率时刻的方法.生存分析,生存分析.运输能力分析分析

更多相关视频

A Cost Effective and Adaptable Scratch Migration Assay
08:59

A Cost Effective and Adaptable Scratch Migration Assay

Published on: June 30, 2020

5.6K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

925

相关实验视频

Last Updated: Sep 12, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
A Cost Effective and Adaptable Scratch Migration Assay
08:59

A Cost Effective and Adaptable Scratch Migration Assay

Published on: June 30, 2020

5.6K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

925

科学领域:

  • 因果推理的原因推理.
  • 生物统计学 生物统计学
  • 流行病学 流行病学

背景情况:

  • 可转移性分析通过将研究结果应用于新种群来评估外部有效性.
  • 现有的方法通常需要个体患者级数据 (IPD),限制使用聚合数据 (AgD).
  • 使用AgD进行信息审查的生存数据的可转移性方法尚未得到充分探索.

研究的目的:

  • 提出一个新的框架,目标聚合数据调整 (TADA),用于使用AgD进行可运输性分析.
  • 解决信息审查和效果修饰器的分配不平衡的挑战.
  • 在数据有限的环境中提高可运输性分析的适用性.

主要方法:

  • 开发了一个两阶段权重框架 (TADA).
  • 嵌入的时间变化的反向概率审查权重.
  • 利用参与权重的时刻方法来调整效果修饰器分布.

主要成果:

  • 塔达有效地控制了来自中度审查的偏见.
  • 该方法通过AgD增强了可运输性分析.
  • 通过广泛的模拟和真实世界肺癌试验案例研究来证明性能.

结论:

  • 塔达为使用AgD进行可运输性分析提供了一种可行的方法,即使有信息审查.
  • 该框架提高了在数据稀缺的情况下发现的临床解释性.
  • 扩大因果推理方法在现实世界应用中的实用性.